Zentalis Pharmaceuticals Signs New Lease at 1359 Broadway

NEW YORK — Empire State Realty Trust, Inc. announced that Zentalis Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that target fundamental biological pathways of cancers, has signed a new lease with ESRT for a 31,362 square foot office space at 1359 Broadway in Manhattan.

“At Zentalis, we are committed to ensuring our employees’ safety and wellbeing, and we are thrilled our new corporate office space will provide our growing team with a healthy and productive work environment to help bring innovative cancer treatments to patients,” commented Dr. Anthony Sun, chairman and chief executive officer of Zentalis Pharmaceuticals. “As we continue to expand our Company’s presence in New York City, minimizing the environmental impacts of our business remains a key priority. We look forward to moving into one of ESRT’s buildings later this year, as the space is dedicated to instilling energy efficiency and sustainable practices.”

With a view of the Broadway pedestrian mall and Herald Square, 1359 Broadway contains 22 stories and 455,849 rentable square feet of modern office space. Tenants enjoy a Wolfgang’s Steakhouse, and a Fresh & Co. right in the building, with plenty of dining, lodging, and retailers in the immediate area.

“Now more than ever, tenants want landlords who provide industry-leading measures for healthy buildings, indoor environmental quality, sustainability and energy efficiency, all of which has been our focus for more than a decade,” said Thomas P. Durels, executive vice president, Real Estate, for ESRT. “Our portfolio was the first in the Americas to be certified under the WELL Health-Safety Rating and we were recently recognized for our leadership in sustainability performance with a 5 Star Rating from GRESB. We are delighted to welcome Zentalis Pharmaceuticals, whose employees will benefit from a healthy workplace environment with state-of-the-art HVAC systems, MERV-13 filters, and bi-polar ionization.”

Justin Royce and Omar Sozkesen from Cushman & Wakefield represented Zentalis Pharmaceuticals, Inc. in the lease negotiations. Landlord representation was provided Keith Cody of ESRT.